Altimmune (ALT) vs Monopar Therapeutics (MNPR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Monopar Therapeutics (MNPR) has outperformed Altimmune (ALT) over the past year, losing 15.0% versus a loss of 32.3%. Over five years, MNPR leads with a +241.3% price change compared with -77.9% for ALT. Monopar Therapeutics is the larger company by market cap ($562.3 million vs $517.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALT | MNPR |
|---|---|---|
| Share price | $2.66 | $83.78 |
| Market cap | $517.42M | $562.35M |
| 1-day change | -0.37% | +5.29% |
| YTD return | -26.32% | +28.30% |
| 1-year return | -32.32% | -14.96% |
| 5-year return | -77.85% | +241.26% |
| EPS (TTM) | $-0.76 | $-2.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.44 | $124.82 |
| 52-week low | $2.56 | $50.07 |
| Distance from 52-week high | -58.70% | -32.88% |
| Average volume | 4.20M | 218.50K |
| Shares outstanding | 194.52M | 6.71M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MNPR has outperformed ALT by 17.4 percentage points over the past year.
ALT vs MNPR FAQ
Which is bigger, Altimmune or Monopar Therapeutics?
Monopar Therapeutics (MNPR) is larger, with a market capitalization of $562.35M compared with $517.42M for Altimmune (ALT).
Which stock has performed better over the past year, ALT or MNPR?
MNPR returned -14.96% over the past 12 months, compared with -32.32% for ALT (price return, excluding dividends). Past performance does not predict future results.
Are Altimmune and Monopar Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.